Literature DB >> 30058373

The Incremental Benefits of the Predictive Low-Glucose Suspend Function Compared to the Low-Glucose Suspend Function as Automation Against Hypoglycemia in Sensor-Augmented Pump Therapy.

Pilar Isabel Beato-Víbora1, Estela Gil-Poch2, Laura Galán-Bueno2, Lucía Lázaro-Martín1, Francisco Javier Arroyo-Díez2.   

Abstract

Entities:  

Keywords:  continuous glucose monitoring; low-glucose suspend function; predictive low-glucose suspend function; sensor-augmented pump therapy; type 1 diabetes

Mesh：

Substances：

Year:  2018        PMID： 30058373      PMCID： PMC6232727          DOI： 10.1177/1932296818791536

Source DB:  PubMed          Journal:  J Diabetes Sci Technol        ISSN： 1932-2968


× No keyword cloud information.
  6 in total

1.  Efficacy and safety of sensor-augmented pump therapy (SAPT) with predictive low-glucose management in patients diagnosed with type 1 diabetes mellitus previously treated with SAPT and low glucose suspend.

Authors:  Ana María Gómez; Diana Cristina Henao; Angelica Imitola; Oscar Mauricio Muñoz; Martín Alonso Rondón Sepúlveda; Laura Kattah; Juan Sebastian Guerrero; Elly Morros; Juan Pablo Llano; Maira García Jaramillo; Fabián León-Vargas
Journal:  Endocrinol Diabetes Nutr (Engl Ed)       Date:  2018-06-18       Impact factor: 1.417

2.  Prevention of Hypoglycemia With Predictive Low Glucose Insulin Suspension in Children With Type 1 Diabetes: A Randomized Controlled Trial.

Authors:  Tadej Battelino; Revital Nimri; Klemen Dovc; Moshe Phillip; Natasa Bratina
Journal:  Diabetes Care       Date:  2017-03-28       Impact factor: 19.112

3.  Reduction in Hypoglycemia With the Predictive Low-Glucose Management System: A Long-term Randomized Controlled Trial in Adolescents With Type 1 Diabetes.

Authors:  Mary B Abraham; Jennifer A Nicholas; Grant J Smith; Janice M Fairchild; Bruce R King; Geoffrey R Ambler; Fergus J Cameron; Elizabeth A Davis; Timothy W Jones
Journal:  Diabetes Care       Date:  2017-11-30       Impact factor: 19.112

4.  Predictive Low-Glucose Insulin Suspension Reduces Duration of Nocturnal Hypoglycemia in Children Without Increasing Ketosis.

Authors:  Bruce A Buckingham; Dan Raghinaru; Fraser Cameron; B Wayne Bequette; H Peter Chase; David M Maahs; Robert Slover; R Paul Wadwa; Darrell M Wilson; Trang Ly; Tandy Aye; Irene Hramiak; Cheril Clarson; Robert Stein; Patricia H Gallego; John Lum; Judy Sibayan; Craig Kollman; Roy W Beck
Journal:  Diabetes Care       Date:  2015-06-06       Impact factor: 19.112

5.  "Let the Algorithm Do the Work": Reduction of Hypoglycemia Using Sensor-Augmented Pump Therapy with Predictive Insulin Suspension (SmartGuard) in Pediatric Type 1 Diabetes Patients.

Authors:  Torben Biester; Olga Kordonouri; Martin Holder; Kerstin Remus; Dorothee Kieninger-Baum; Tanja Wadien; Thomas Danne
Journal:  Diabetes Technol Ther       Date:  2017-01-18       Impact factor: 6.118

6.  Effectiveness of Automated Insulin Management Features of the MiniMed® 640G Sensor-Augmented Insulin Pump.

Authors:  Alex Zhong; Pratik Choudhary; Chantal McMahon; Pratik Agrawal; John B Welsh; Toni L Cordero; Francine R Kaufman
Journal:  Diabetes Technol Ther       Date:  2016-09-27       Impact factor: 6.118
  6 in total
  2 in total

1.  Real-World Hypoglycemia Avoidance with a Continuous Glucose Monitoring System's Predictive Low Glucose Alert.

Authors:  Sarah Puhr; Mark Derdzinski; John B Welsh; Andrew Scott Parker; Tomas Walker; David A Price
Journal:  Diabetes Technol Ther       Date:  2019-03-22       Impact factor: 6.118

2.  Long-term efficacy of sensor-augmented pump therapy (Minimed 640G system) combined with a telemedicine follow-up in patients with type 1 diabetes: A real life study.

Authors:  Léonie Makuété Notemi; Lamia Amoura; Fatéma Fall Mostaine; Laurent Meyer; Dominique Paris; Samy Talha; Julien Pottecher; Laurence Kessler
Journal:  J Clin Transl Endocrinol       Date:  2022-10-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.